Skip to content

Ayurvedic management of Gingivitis with the help of priyangwadi churna, triphla churnawith or without raktamokshana.

â??ROLE OF PRIYANGAVADI CHURNA PRATISARANA, TRIPHALA CHURNA ORALLY, WITH OR WITHOUT RAKTAMOKSHANA (PRACHCHANA VIDHI) IN THE MANAGEMENT OF SHITADA (GINGIVITIS)â??

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031767
Enrollment
100
Registered
2021-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K050- Acute gingivitis Health Condition 2: K050- Acute gingivitis

Interventions

Intervention1: Priyangvadi Churna, Triphala Churna, Raktamokshana: Priyangvadi churna 2 gm BD for pratisarana, Triphla Churna 3gm BD orally for one month, Raktmokshana (Prachchan Vidhi)4 times in mont

Sponsors

ITRA GAU Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient of either sex aged between 18 to 60 years of age presenting with signs and symptoms of Shitada (Gingivitis) described as per Ayurveda and Modern Science will be included in the study. 2. The diagnosis of the disease shall be done with signs and symptoms of Shitada (Gingivitis) i.e. Akasmata Rakta Srava (Bleeding), Shotha (Inflammation), Krishnata (Discoloration of gums), Mukha Daurgandhya (Halitosis), Vedana (Pain), Dantamamsa Prakledata (Moistness), Paka (Pus discharge) and Dantamamsa Mriduta (Sponginess).

Exclusion criteria

Exclusion criteria: 1.Patients below18 years and more than 60 years of age. 2.Patient with periodontal pocket with pus discharge. 3.Patients with evidence of malignancy, HIV and Diabetes Mellitus. 4.Any systemic disorder which may alter the result of the study i.e, Haemophilia or other bleeding disorders. 5.Pregnant women shall be excluded. 6. Patients who are using anticoagulant drugs like aspirin etc. will be excluded. 7.The patients taking any other systemic drugs which can alter the result of the study.

Design outcomes

Primary

MeasureTime frame
Relief in sign and symptoms of Shitada (Gingivitis) after 1 month.Timepoint: Relief in sign and symptoms of Shitada (Gingivitis) after 1 month.

Secondary

MeasureTime frame
Improves quality of life of the person,after one month treatment.Timepoint: 4 weeks and 8 weeks

Countries

India

Contacts

Public ContactDr D B Vaghela

Institute of Teaching and Research in Ayurveda

drvaghela@rediffmail.com9825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026